Theravance Biopharma, Inc. TBPH
$17.04
+0.06%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 8-K | FORM 8-K | 2026-08-25 | View → |
| 4 | Insider transaction | 2026-08-24 | View → |
| 4 | Insider transaction | 2026-08-24 | View → |
| 4 | Insider transaction | 2026-08-24 | View → |
| 4 | Insider transaction | 2026-08-24 | View → |
| 4 | Insider transaction | 2026-08-24 | View → |
| 10-Q | 10-Q | 2026-08-11 | View → |
| 8-K | FORM 8-K | 2026-08-10 | View → |
| 4 | PRIMARY DOCUMENT | 2026-07-08 | View → |
| 4 | PRIMARY DOCUMENT | 2026-07-01 | View → |
| 8-K | FORM 8-K | 2026-06-29 | View → |
| 4 | Insider transaction | 2026-06-23 | View → |
| 8-K | FORM 8-K | 2026-06-23 | View → |
| 4 | Insider transaction | 2026-06-17 | View → |
| 4 | Insider transaction | 2026-06-16 | View → |
| 4 | Insider transaction | 2026-06-16 | View → |
| 4 | Insider transaction | 2026-06-16 | View → |
| 4 | Insider transaction | 2026-06-16 | View → |
| 4 | Insider transaction | 2026-06-16 | View → |
| 8-K | FORM 8-K | 2026-06-12 | View → |
| 4 | Insider transaction | 2026-05-22 | View → |
| 4 | Insider transaction | 2026-05-22 | View → |
| 4 | Insider transaction | 2026-05-22 | View → |
| 4 | Insider transaction | 2026-05-22 | View → |
| 4 | Insider transaction | 2026-05-22 | View → |
| 10-Q | 10-Q | 2026-05-07 | View → |
| 8-K | FORM 8-K | 2026-05-07 | View → |
| DEF 14A | DEF 14A | 2026-04-28 | View → |
| 4 | Insider transaction | 2026-04-03 | View → |
| 4 | Insider transaction | 2026-04-03 | View → |
| 4 | Insider transaction | 2026-04-03 | View → |
| 4 | Insider transaction | 2026-04-03 | View → |
| 8-K | FORM 8-K | 2026-03-30 | View → |
| 10-K | 10-K | 2026-03-23 | View → |
| 8-K | FORM 8-K | 2026-03-19 | View → |
| 4 | Insider transaction | 2026-03-18 | View → |
| 8-K | FORM 8-K | 2026-03-03 | View → |
| 4 | Insider transaction | 2026-02-24 | View → |
| 4 | Insider transaction | 2026-02-24 | View → |
| 4 | Insider transaction | 2026-02-24 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $17.04
- Market Cap
- $884.18 million
- 52-Week Range
- $10.82 – $21.03
- Average Volume
- 549K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.